Renaissance Technologies’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.85M | Buy |
837,700
+156,273
| +23% | +$1.46M | 0.01% | 1228 |
|
|
2025
Q1 | $8.37M | Buy |
681,427
+462
| +0.1% | +$5.68K | 0.01% | 1104 |
|
|
2024
Q4 | $9M | Buy |
+680,965
| New | +$9M | 0.01% | 1082 |
|
|
2024
Q3 | – | Sell |
-214,300
| Closed | -$4.4M | – | 3854 |
|
|
2024
Q2 | $4.4M | Buy |
214,300
+135,200
| +171% | +$2.78M | 0.01% | 1390 |
|
|
2024
Q1 | $1.88M | Buy |
+79,100
| New | +$1.88M | ﹤0.01% | 2071 |
|
|
2023
Q4 | – | Sell |
-218,300
| Closed | -$3.17M | – | 4100 |
|
|
2023
Q3 | $3.17M | Buy |
+218,300
| New | +$3.17M | 0.01% | 1570 |
|
|
2023
Q1 | – | Sell |
-81,200
| Closed | -$2.07M | – | 4357 |
|
|
2022
Q4 | $2.07M | Buy |
+81,200
| New | +$2.07M | ﹤0.01% | 2046 |
|
|
2022
Q2 | – | Sell |
-182,100
| Closed | -$3.17M | – | 4548 |
|
|
2022
Q1 | $3.17M | Buy |
+182,100
| New | +$3.17M | ﹤0.01% | 1884 |
|
|
2020
Q3 | – | Sell |
-94,700
| Closed | -$1.4M | – | 3661 |
|
|
2020
Q2 | $1.4M | Sell |
94,700
-392,900
| -81% | -$5.82M | ﹤0.01% | 2373 |
|
|
2020
Q1 | $5.35M | Sell |
487,600
-7,900
| -2% | -$86.7K | 0.01% | 1520 |
|
|
2019
Q4 | $4.35M | Sell |
495,500
-1,500
| -0.3% | -$13.2K | ﹤0.01% | 1940 |
|
|
2019
Q3 | $3.71M | Buy |
497,000
+65,100
| +15% | +$486K | ﹤0.01% | 1961 |
|
|
2019
Q2 | $4.02M | Buy |
431,900
+117,300
| +37% | +$1.09M | ﹤0.01% | 1932 |
|
|
2019
Q1 | $1.65M | Buy |
314,600
+85,500
| +37% | +$449K | ﹤0.01% | 2412 |
|
|
2018
Q4 | $1.02M | Sell |
229,100
-50,200
| -18% | -$223K | ﹤0.01% | 2561 |
|
|
2018
Q3 | $2.26M | Buy |
279,300
+237,000
| +560% | +$1.92M | ﹤0.01% | 2214 |
|
|
2018
Q2 | $297K | Sell |
42,300
-10,200
| -19% | -$71.6K | ﹤0.01% | 2965 |
|
|
2018
Q1 | $747K | Buy |
52,500
+26,800
| +104% | +$381K | ﹤0.01% | 2778 |
|
|
2017
Q4 | $225K | Buy |
+25,700
| New | +$225K | ﹤0.01% | 3102 |
|